Skip to main content
SpringerLink
Log in

Presumed Ocular Histoplasmosis Syndrome

  • Chapter
  • First Online:
Uveitis

  • 1070 Accesses

Abstract

Presumed ocular histoplasmosis is a choroidopathy, typically characterized by atrophic chorioretinal scars, peripapillary atrophy, and the absence of vitritis. The ocular manifestations are presumably secondary to a complex and poorly defined interaction between the fungal organism Histoplasma capsulatum and the host immune response. Patients without choroidal neovascularization require monitoring without treatment. When choroidal neovascularization develops in the macula, intraocular anti-VEGF agents are the preferred option for therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nussenblatt RB, Whitcup SM, Palestine AG. Ocular histoplasmosis. In Nussenblatt RB et al., editors. Uveitis: fundamentals and clinical practice, 2nd ed. St. Louis: Mosby; 1996.

    Google Scholar 

  2. Craig EL, Svie T. Histoplasma capsulatum in human ocular tissue. Arch Ophthalmol. 1974;91:285–9.

    Article  CAS  PubMed  Google Scholar 

  3. Goldstein BG, Buettuer H. Histoplasmic endophthalmitis: a clinical correlation. Arch Ophthalmol. 1983;101:774.

    Article  CAS  PubMed  Google Scholar 

  4. Reid JD, Schere JH, Herbut PA, Irving H. Systemic histoplasmosis diagnosed before death and produced experimentally in guinea pigs. J Lab Clin Med. 1942;27:219–23.

    Google Scholar 

  5. Krause AC, Hopkins WG. Ocular manifestations of histoplasmosis. Am J Ophthalmol. 1951;34:564–6.

    Article  CAS  PubMed  Google Scholar 

  6. Woods AC, Wahlen HE. The probable role of benign histoplasmosis in the etiology of granulomatous uveitis. Am J Ophthalmol. 1960;49:205–20.

    Article  CAS  PubMed  Google Scholar 

  7. Prasad AG, Van Gelder RN. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol. 2005;16:364–8.

    Article  PubMed  Google Scholar 

  8. Ongkosuwito JV, Kortbeek LM, Van der Lelij A, Molicka E, Kijlstra A, de Smet MD, Suttorp-Schulten MS. Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands. Br J Ophthalmol. 1999;83:535–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Braunstein RA, Rusen DA, Bird AC. Ocular histoplasmosis syndrome in the United Kingdom. Br J Ophthalmol. 1974;58:893.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Braley RE, Meredith TA, Aaberg TM, Koethe SM, Witkowski JA. The prevalence of HLA-B7 in presumed ocular histoplasmosis. Am J Ophthalmol. 1978;85:859.

    Article  CAS  PubMed  Google Scholar 

  11. Meredith TA, Smith RP, Braley RE, Witkowski JA, Koethe SM. The prevalence of HLA-B7 and presumed ocular histoplasmosis in patients with peripheral atrophic scars. Am J Ophthalmol. 1978;86:325.

    Article  CAS  PubMed  Google Scholar 

  12. Meredith TA, Smith RE, Dueqesnoy RJ. Association of HLA-DR2 antigen with presumed ocular histoplasmosis. Am J Ophthalmol. 1980;89:70.

    Article  CAS  PubMed  Google Scholar 

  13. Hawkins BS, Alexander J, Schachat AP. Ocular histoplasmosis. In: Ryan SJ, Schahchat AP, editors. Retina. Missouri: Mosby; 2001.

    Google Scholar 

  14. Ryan SJ. Histopathologic correlates of presumed ocular histoplasmosis. Int Ophthalmol Clin. 1975;15:125.

    Article  CAS  PubMed  Google Scholar 

  15. Check IJ, Diddle KR, Jay WM, Merker R, Hunter RL. Lymphocyte stimulation by yeast phase Histoplasma capsulatum in presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1979;87:311.

    Article  CAS  PubMed  Google Scholar 

  16. Khalil MK. Histopathology of presumed ocular histoplasmosis. Am J Ophthalmol. 1982;94:369–76.

    Article  CAS  PubMed  Google Scholar 

  17. Kaplan HJ, Waldrep JC. Immunological basis of presumed ocular histoplasmosis. Int Ophthalmol Clin. 1983;23(2):19–31.

    Article  CAS  PubMed  Google Scholar 

  18. Smith RE, O’Connor GR, Halde CJ, Scalarone MA, Easterbrook WM. Clinical course in rabbits after experimental induction of ocular histoplasmosis. Am J Ophthalmol. 1973;76:284.

    Article  CAS  PubMed  Google Scholar 

  19. Baskin MA, Jampol LM, Huamonte FU, Rabb MF, Vygantas CM, Wyhinny G. Macular lesions in blacks with the presumed ocular histoplasmosis syndrome. Am J Ophtahlmol. 1980;89:77–83.

    Article  CAS  Google Scholar 

  20. Smith RE, Ganley JP, Knox DL. Presumed ocular histoplasmosis II. Patterns of periperal and peripapillary scarring in persons with nonmacular disease. Arch Ophthalmol. 1972;87:251–7.

    Article  CAS  PubMed  Google Scholar 

  21. Fountain JA, Schlaegel TF. Linear streaks of the equator in the presumed ocular histoplasmosis syndrome. Arch Ophthalmol. 1981;99:246–8.

    Article  CAS  PubMed  Google Scholar 

  22. Schlaegel TF. The natural history of histo spots in the disc and macular area. Int Ophthal Clin. 1975;15:19.

    Article  PubMed  Google Scholar 

  23. Lewis ML, Van Newkirk MR, Gass JD. Follow-up study of presumed ocular histoplasmosis syndrome. Ophthalmology. 1980;87:390.

    Article  CAS  PubMed  Google Scholar 

  24. Schlaegel TF, Kenney D. Changes around the optic nerve head in presumed ocular histoplasmosis. Am J Ophthalmol. 1966;62:454–8.

    Article  PubMed  Google Scholar 

  25. Kranias G. Vitreous hemorrhage secondary to presumed ocular histoplasmosis syndrome. Ann Ophthalmol. 1985;17:295.

    CAS  PubMed  Google Scholar 

  26. Krill AE, Christi MI, Klien BA, Newell FW, Potts AM. Multifocal inner choroiditis. Trans Am Acad Ophthalmol Otolaryngol. 1969;73:222.

    CAS  PubMed  Google Scholar 

  27. Dreyer RF, Gass JDM. Multifocal choroiditis and panuveitis: a syndrome that mimics ocular histoplasmosis. Arch Ophthalmol. 1984;102:1776.

    Article  CAS  PubMed  Google Scholar 

  28. Deutsch T, Tessler H. Inflammatory pseudo histoplasmosis. Ann Ophthalmol. 1985;17:461.

    CAS  PubMed  Google Scholar 

  29. Giles CL, Falls HF. Further evaluation of amphotericin-B therapy in presumptive histoplasmosis chorioretinitis. Am J Ophthalmol. 1961;51:588–98.

    Article  CAS  PubMed  Google Scholar 

  30. Oliver A, Ciulla TA, Comer GM. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment. Curr Opin Ophthalmol. 2005;16:160–5.

    Article  PubMed  Google Scholar 

  31. Macular Photocoagulation Study Group. Argon laser photocoagulaion for ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1987;105:1499–507.

    Article  Google Scholar 

  32. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results form randomized clinical trials. Arch Ophthalmol. 1991;109:1109–14.

    Article  Google Scholar 

  33. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, Donati G, Laqua H, Barbazetto I, Gragoudas ES, Lane AM, Birngruber R, van den Bergh H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. A preliminary study of photodynamic therapy using verteprorfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 2000;118:327.

    Article  CAS  PubMed  Google Scholar 

  34. Rosenfeld PJ, Saperstein DA, Bressler NM, Reaves TA, Sickenberg M, Rosa RH Jr, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology. 2004;111:1725–33.

    Article  PubMed  Google Scholar 

  35. Thomas M, Kaplan H. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1991;111:1.

    Article  CAS  PubMed  Google Scholar 

  36. Hawkins BS, Bressler NM, Bressler SB, Davidorf FH, Hoskins JC, Marsh MJ, Miskala PH, Redford M, Sternberg P Jr, Thomas MA, Toth CA. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: submacular surgery trials (SST) group H trial: SST report no. 9. Arch Ophthalmol. 2004;122:1597–611.

    Article  PubMed  Google Scholar 

  37. Berger A, Conway M, Del Priore LV, Walker RS, Pollack JS, Kaplan HJ. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol. 1997;115:991.

    Article  CAS  PubMed  Google Scholar 

  38. Holekamp N, Thomas M, Dickinson J, Valluri S. Surgical removal of choroidal neovascularization in presumed ocular histoplasmosis. Ophthalmology. 1997;104:22.

    Article  CAS  PubMed  Google Scholar 

  39. Schlaegel TF. Treatment of the POHS. In: Schlaegel TF, editor. Ocular histoplasmosis. New York: Grune and Stratton; 1977.

    Google Scholar 

  40. Nielsen JS, Fick TA, Saggau DD, Barnes CH. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina. 2012;32:468–72.

    Article  CAS  PubMed  Google Scholar 

  41. Adan A, Navarro M, Casaroli-Marano RP, Ortiz S, Molina JJ. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Graefes Arch Clin Exp Ophthalmol. 2007;245:1873.

    Article  CAS  PubMed  Google Scholar 

  42. Singerman LJ, Wong BA, Smith S. Spontaneous visual improvement in the first affected eye of patients with bilateral disciform scars. Retina. 1985;5:135.

    Article  CAS  PubMed  Google Scholar 

  43. Hawkins BS, Ganley JP. Risk of visual impairment attributable to ocular histoplasmosis. Arch Ophthalmol. 1994;112:655–66.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, 243 Charles St., Boston, MA, 02114, USA

    Lindsay Grotting

Authors
  1. Lindsay Grotting
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lindsay Grotting .

Editor information

Editors and Affiliations

  1. Ocular Immunology and Uveitis Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA

    George N. Papaliodis

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Grotting, L. (2017). Presumed Ocular Histoplasmosis Syndrome. In: Papaliodis, G. (eds) Uveitis. Springer, Cham. https://doi.org/10.1007/978-3-319-09126-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09126-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09125-9

  • Online ISBN: 978-3-319-09126-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation